Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Abstract
The RNA-binding protein Bicaudal C is an important regulator of embryonic development in C. elegans, Drosophila and Xenopus. In mouse, bicaudal C (Bicc1) mutants are characterized by the formation of fluid-filled cysts in the kidney and by expansion of epithelial ducts in liver and pancreas. This phenotype is reminiscent of human forms of polycystic kidney disease (PKD). Here, we now provide data that Bicc1 functions by modulating the expression of polycystin 2 (Pkd2), a member of the transient receptor potential (TRP) superfamily. Molecular analyses demonstrate that Bicc1 acts as a post-transcriptional regulator upstream of Pkd2. It regulates the stability of Pkd2 mRNA and its translation efficiency. Bicc1 antagonized the repressive activity of the miR-17 microRNA family on the 3'UTR of Pkd2 mRNA. This was substantiated in Xenopus, in which the pronephric defects of bicc1 knockdowns were rescued by reducing miR-17 activity. At the cellular level, Bicc1 protein is localized to cytoplasmic foci that are positive for the P-body markers GW182 and HEDLs. Based on these data, we propose that the kidney phenotype in Bicc1(-/-) mutant mice is caused by dysregulation of a microRNA-based translational control mechanism.
Fig. 3. Bicc1 regulates Pkd2. (A-C) qPCR analysis for mouse Pkd1, Pkd2 and Pkhd1 mRNA levels in Bicc1+/+ (dark gray) and Bicc1−/− (light gray) littermates. The averages and s.d. from six kidney pairs at E15.5 and four pairs at E18.5 are shown (*, P<0.05, Student's t-test). (D) Western blot analysis comparing Pkd2 protein levels in E15.5 kidneys from two Bicc1 mouse litters (#55 and #65) of the indicated genotypes using the Pkd2-specific antibody from Santa Cruz. Actin served as a loading control. (E) Quantification of multiple Pkd2 western blot analyses comparing several mouse litters at E15.5 and normalized to actin. Average values and s.d. are indicated (*, P<0.05, Student's t-test). (F) Whole-mount in situ hybridization for Pkd2 mRNA on uninjected and xBicC-MO1+2-injected Xenopus embryos at stage 39.
Fig. 4. Bicc1 is epistatic to Pkd2. (A-A′) Analysis of the expression of nbc-1 in the Xenopus late distal tubule at stage 39 by whole-mount in situ hybridization of uninjected control embryos, and embryos radially injected with xBicC-MO1+2 in the presence or absence of a single injection of 2 ng pkd2 mRNA. (B) Quantification of the expression of nbc-1 in the late distal tubule from the experiments shown in A-A′. Black, bilateral expression; white, no expression; gray, unilateral expression rescued by co-injected mRNA. The number of embryos analyzed is indicated. (C-D) Reciprocal experiments to those in A-B using Xenopus embryos injected with either Pkd2-MO alone or together with pkd2-myc or bicc1 mRNA. Co-injection with pkd2-myc rescued nbc-1 expression, whereas co-injection with bicc1 did not. (E) Flow diagram outlining the proposed mechanism of Bicc1 activity.
Fig. 7. Cross-talk between Bicc1 and the miR-17 miRNA family. (A) Alignment of the Xenopus miR-17 family members. Mature forms are highlighted in yellow. The sequence targeted by the miR-17 antisense MO (miR-17-MO) is indicated by the black line. The nucleotides shared between miR-17-MO and the individual members are indicated in red. (B-B′) Analysis of the expression of nbc-1 by whole-mount in situ hybridization of uninjected control embryos, embryos injected with xBicC-MO1+2 alone or with miR-17-MO. Arrowheads indicate the expression of nbc-1 in the Xenopus late distal tubule. Note that this expression domain is rescued upon co-injection of the two antisense MOs. (C) Quantification of the experiments shown in B-B′. Black, bilateral expression; white, reduced or no expression; gray, unilateral, rescued expression in the late distal tubule. (D,D′) Models for the post-transcriptional regulation of Pkd2 mRNA by the miR-17 family in the absence or presence of Bicc1.
Fig. 3. Pkd2 expression at stg. 39
Fig. S5. pkd2 mRNA and protein expression in Xenopus. (A) Whole-mount in situ hybridization detecting expression of pkd2 mRNA in the Xenopus pronephros. Inset is a magnified image of the pronephric tubules and the nephrostomes (arrowheads). (B-C′′) Immunofluorescence using antibodies against Pkd2 (AB9088, Millipore; red) and acetylated α-tubulin (green). Note that Pkd2 is expressed in the cilia of the duct (B-B′′) and those of the multiciliated cells in the nephrostomes (C-C′′) present in the Xenopus pronephros. (D-E′′) Immunofluorescence analysis of the cilia in the pronephric tubules using antibodies against Pkd2 (red) and acetylated α-tubulin (green) comparing uninjected Xenopus embryos with embryos injected with Pkd2-MO (400 fmol) at stage 40. Nuclei were counterstained with DAPI.
Fig. S6. Loss of Pkd2 results in a PKD-like phenotype in Xenopus embryos. (A-B′) Xenopus embryos microinjected with antisense MOs against pkd2 (Pkd2-MO) developed a PKD-like phenotype. Morphological analysis showed severe edema formation (A,A′), while histological analysis using Hematoxylin and Eosin staining detected dilated pronephric tubules (B,B′). en, endoderm; no, notochord; nt, neural tube; pn, pronephros; so, somites, (C) Schematic of the Xenopus pronephros indicating the segments expressing the marker genes nbc-1 and lim1 (lhx1). (D-E′′) Whole-mount in situ hybridization of Xenopus embryos injected with xBicC-MO1+2, Pkd2-MO or uninjected controls at stage 39 with nbc-1 (D-D′′) and Lim1 (E-E′′). Arrowheads indicate the expression of these two genes in the late distal tubule that is lost in the antisense MO-injected embryos.
Fig. S7. Expression of pronephric marker genes in pkd2 morphants. (A-E′) Whole-mount in situ hybridization of uninjected control and Pkd2-MO-injected Xenopus embryos at stage 39 with Nephrin (A,A′), xSGLT-1K (B,B′), NKCC2 (C,C′), NCC (D,D′) and β1-Na/K ATPase (E,E′) mRNA. Note that the expression of NCC, a marker for late distal tubule and pronephric duct, was reduced in Pkd2-MO-injected embryos. (F) Schematic of the Xenopus pronephros indicating the markers analyzed.
Agrawal,
The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1.
2009, Pubmed,
Xenbase
Agrawal,
The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1.
2009,
Pubmed
,
Xenbase
Anderson,
Stress granules: the Tao of RNA triage.
2008,
Pubmed
Blum,
Ciliation and gene expression distinguish between node and posterior notochord in the mammalian embryo.
2007,
Pubmed
,
Xenbase
Burn,
Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. The American PKD1 Consortium (APKD1 Consortium).
1995,
Pubmed
Charlesworth,
Cytoplasmic polyadenylation element (CPE)- and CPE-binding protein (CPEB)-independent mechanisms regulate early class maternal mRNA translational activation in Xenopus oocytes.
2004,
Pubmed
,
Xenbase
Chicoine,
Bicaudal-C recruits CCR4-NOT deadenylase to target mRNAs and regulates oogenesis, cytoskeletal organization, and its own expression.
2007,
Pubmed
Cloonan,
The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition.
2008,
Pubmed
Cogswell,
Positional cloning of jcpk/bpk locus of the mouse.
2003,
Pubmed
Dressler,
The cellular basis of kidney development.
2006,
Pubmed
,
Xenbase
Drummond,
Kidney development and disease in the zebrafish.
2005,
Pubmed
Filipowicz,
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
2008,
Pubmed
Flaherty,
New mouse model for polycystic kidney disease with both recessive and dominant gene effects.
1995,
Pubmed
Foshay,
miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation.
2009,
Pubmed
Franks,
TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elements.
2007,
Pubmed
Guay-Woodford,
Murine models of polycystic kidney disease: molecular and therapeutic insights.
2003,
Pubmed
Hildebrandt,
A novel gene encoding an SH3 domain protein is mutated in nephronophthisis type 1.
1997,
Pubmed
Hogan,
Organogenesis: molecular mechanisms of tubulogenesis.
2002,
Pubmed
Hughes,
The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains.
1995,
Pubmed
Kedersha,
Mammalian stress granules and processing bodies.
2007,
Pubmed
Liu,
A role for the P-body component GW182 in microRNA function.
2005,
Pubmed
Ma,
Effects of different fixatives on beta-galactosidase activity.
2002,
Pubmed
Mahone,
Localized Bicaudal-C RNA encodes a protein containing a KH domain, the RNA binding motif of FMR1.
1995,
Pubmed
Maisonneuve,
Bicaudal C, a novel regulator of Dvl signaling abutting RNA-processing bodies, controls cilia orientation and leftward flow.
2009,
Pubmed
,
Xenbase
Markowitz,
Polycystin-2 expression is developmentally regulated.
1999,
Pubmed
Mendell,
miRiad roles for the miR-17-92 cluster in development and disease.
2008,
Pubmed
Mochizuki,
PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein.
1996,
Pubmed
Mohler,
Dominant maternal-effect mutations of Drosophila melanogaster causing the production of double-abdomen embryos.
1986,
Pubmed
Møbjerg,
Morphology of the kidney in larvae of Bufo viridis (Amphibia, Anura, Bufonidae).
2000,
Pubmed
,
Xenbase
NULL,
Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. The International Polycystic Kidney Disease Consortium.
1995,
Pubmed
Nauta,
Renal and biliary abnormalities in a new murine model of autosomal recessive polycystic kidney disease.
1993,
Pubmed
Onuchic,
PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats.
2002,
Pubmed
Parker,
P bodies and the control of mRNA translation and degradation.
2007,
Pubmed
Pennekamp,
The ion channel polycystin-2 is required for left-right axis determination in mice.
2002,
Pubmed
Raciti,
Organization of the pronephric kidney revealed by large-scale gene expression mapping.
2008,
Pubmed
,
Xenbase
Rehwinkel,
A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing.
2005,
Pubmed
Saffman,
Premature translation of oskar in oocytes lacking the RNA-binding protein bicaudal-C.
1998,
Pubmed
Shan,
MicroRNA MiR-17 retards tissue growth and represses fibronectin expression.
2009,
Pubmed
Shillingford,
The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.
2006,
Pubmed
Stagner,
The polycystic kidney disease-related proteins Bicc1 and SamCystin interact.
2009,
Pubmed
Stoecklin,
ARE-mRNA degradation requires the 5'-3' decay pathway.
2006,
Pubmed
Suh,
The GLD-2 poly(A) polymerase activates gld-1 mRNA in the Caenorhabditis elegans germ line.
2006,
Pubmed
Sweeney,
Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor.
2000,
Pubmed
Torres,
Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities.
2007,
Pubmed
Tran,
Xenopus Bicaudal-C is required for the differentiation of the amphibian pronephros.
2007,
Pubmed
,
Xenbase
Vasudevan,
AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2.
2007,
Pubmed
Vasudevan,
Switching from repression to activation: microRNAs can up-regulate translation.
2007,
Pubmed
Ventura,
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters.
2008,
Pubmed
Wang,
A regulatory cytoplasmic poly(A) polymerase in Caenorhabditis elegans.
2002,
Pubmed
Ward,
The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.
2002,
Pubmed
Wessely,
The Xenopus homologue of Bicaudal-C is a localized maternal mRNA that can induce endoderm formation.
2000,
Pubmed
,
Xenbase
Wessely,
Identification and expression of the mammalian homologue of Bicaudal-C.
2001,
Pubmed
,
Xenbase
Wilson,
Cystic disease of the kidney.
2007,
Pubmed
Wu,
Cardiac defects and renal failure in mice with targeted mutations in Pkd2.
2000,
Pubmed
Xiong,
A novel gene encoding a TIG multiple domain protein is a positional candidate for autosomal recessive polycystic kidney disease.
2002,
Pubmed
Zhou,
Proximo-distal specialization of epithelial transport processes within the Xenopus pronephric kidney tubules.
2004,
Pubmed
,
Xenbase